Pfizer (PFE) has been one of the most searched ... That's because we believe the present value of its future stream of ...

A debate over the healthcare system erupted on X, pitting Mark Cuban against Elizabeth Warren over the root causes of soaring drug prices.

Pfizer is undervalued as markets fixate on its patent cliff, overlooking strong cash flows, pipeline upside, and a 7% yield.

Pfizer investors have seen brighter days—and then the last three years happened. Pfizer's share price has plummeted 51% over ...

Pfizer (NYSE:PFE) stock is a biopharmaceutical firm that had a magnificent breakout in 2021 as the worst of the pandemic sent ...

Pfizer’s stock is catching a cold, slipping $0.24 to land near $24.16 while option traders wrap themselves in bearish ...

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Pfizer (PFE – Research Report) and Sagimet Biosciences, Inc. Class A (SGMT – R ...

This was the stock's third consecutive day of losses.

The most notable increase was in Bristol-Myers Squibb Co (NYSE:BMY), with an additional 14,342,846 shares, bringing the total ...

The surge in China-listed biotech firms is further evidence that the mainland is becoming a center for global innovation ...

Valued at $1.25 billion, the deal expands BioNTech’s cancer drug portfolio and heads off royalty costs it could have owed ...

The drug, Ibtrozi, will now vie for market share in an indication where multiple large pharmaceutical companies have already ...